Ykrita
1 known investors
Ykrita Lifesciences develops EBDLR v2.0, a lightweight and portable medical device designed to supplement liver function and enable regeneration in patients with acute liver failure or acute-on-chronic liver failure. The device targets patients who are not candidates for liver transplantation.
BiotechDeep TechMedical Devices
Investors Β· 1
Frequently asked questions
- What does Ykrita do?
- Ykrita Lifesciences develops EBDLR v2.0, a lightweight and portable medical device designed to supplement liver function and enable regeneration in patients with acute liver failure or acute-on-chronic liver failure. The device targets patients who are not candidates for liver transplantation.
- Who are Ykrita's investors?
- Ykrita's investors include Inflexor Ventures.